
Agomab Therapeutics Secures $89M in Series D Funding to Accelerate Fibrosis Treatment Pipeline
Quick Summary Investment Amount: Agomab Therapeutics raised $89 million in Series D financing. Key Backers: Led by new investors Sanofi and Invus, with participation from